Sugary Drinks May Increase Hair Loss Risk, Study Finds
August 27, 2025
12:58 pm
Sugary drinks have long been linked to obesity, diabetes, and heart problems, but new research suggests they may also increase the risk of hair loss.
Sugary drinks have long been linked to obesity, diabetes, and heart problems, but new research suggests they may also increase the risk of hair loss.
A recent report by the Punjab Healthcare Commission (PHC) has raised serious concerns about infection control in public hospitals across the province. The report shows
Beetroot Juice is gaining attention as a natural pre-workout drink for fitness enthusiasts. Many people are looking for healthy ways to improve their workout performance.
Loneliness and social isolation are emerging as key risk factors for the development of type 2 diabetes. Recent studies have shown that people who experience
Federal Health Minister Syed Mustafa Kamal announced that every medicine sold in Pakistan will carry a barcode within the next three months. This new system
Experts Debunk Myths Linking COVID-19 Vaccine to Heart Attacks Recent reports of sudden deaths have raised concerns about the COVID-19 vaccine causing heart attacks. However,
A growing number of young men and women are joining gyms across the country, motivated by a desire to prevent heart conditions and other lifestyle-related
The Health CEO of Pakpattan and the Medical Superintendent (MS) have been arrested following the death of 20 children at DHQ Hospital. Punjab Chief Minister
Loneliness Linked to Over 800,000 Deaths Annually, WHO Warns in Global Health Report The World Health Organization (WHO) has sounded the alarm on the growing
As Eidul Azha approaches, health experts are urging the public to practice moderation and safe food handling when consuming red meat to prevent health risks,
Austrian Startup Tec-Innovation Launches InnoMake: A Smart Shoe to Aid Visually Impaired and Elderly Mobility Austrian startup Tec-Innovation has introduced InnoMake, an innovative smart shoe
A groundbreaking international clinical trial has revealed that a new immunotherapy drug, pembrolizumab, has doubled the period during which patients with advanced head and neck
